2021年
- Fanconi Anemia Complementation Group E (FANCE), a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma
Junichi Takahashi, Takaaki Masuda, Akihiro Kitagawa, Taro Tobo, Yusuke Nakano, Tadashi Abe, Yuki Ando, Keisuke Kosai, Yuta Kobayashi, Yoshihiro Matsumoto, Tomoharu Yoshizumi, Masaki Mori, Koshi Mimori
Oncology. 2021 Nov 1. doi: 10.1159/000520582. Online ahead of print.PMID: 34724663
- Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy
Takaaki Masuda, Osamu Niizeki, Takashi Niizeki, Kenji Fujiyoshi, Yuki Ando, Hiroshi Niizeki, Koshi Mimori
Case Rep Oncol. 2021 Sep 3;14(3):1261-1265. doi: 10.1159/000517854. eCollection Sep-Dec 2021.PMID: 34720925
- GET4 is a novel driver gene in CRC that regulates the localization of BAG6, a nucleo-cytoplasmic shuttling protein
Kensuke Koike, Takaaki Masuda, Kuniaki Sato, Atsushi Fujii, Hiroaki Wakiyama, Taro Tobo, Junichi Takahashi, Yushi Motomura, Takafumi Nakano, Hideyuki Saito, Yoshihiro Matsumoto, Hajime Otsu, Kazuki Takeishi, Yusuke Yonemura, Koshi Mimori, Takashi Nakagawa
Cancer Sci. 2021 Oct 26. doi: 10.1111/cas.15174. Online ahead of print.PMID: 34704338
- Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer
Qingjiang Hu, Takaaki Masuda, Kensuke Koike, Kuniaki Sato, Taro Tobo, Shotaro Kuramitsu, Akihiro Kitagawa, Atsushi Fujii, Miwa Noda, Yusuke Tsuruda, Hajime Otsu, Yosuke Kuroda, Shuhei Ito, Eiji Oki, Koshi Mimori
Sci Rep. 2021 Sep 28;11(1):19178. doi: 10.1038/s41598-021-98485-9.PMID: 34584127
- Clinical usefulness of a novel fluorescence technique for the intraoperative diagnosis of surgical margins in patients with breast cancer
Ueo H, Ueo H, Minoura I, Gamachi A, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Kai Y, Kubota Y, Urano Y, Mori M, Mimori K.
Br J Surg. 2021 Aug 24:znab265. doi: 10.1093/bjs/znab265. Online ahead of print.PMID: 34428279
- The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K.
Cancer Res.2021 Aug 19:canres.0653.2021. doi: 10.1158/0008-5472.CAN-21-0653. Online ahead of print.PMID: 34413060
- Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells
Shotaro Kuramitsu, Takaaki Masuda, Qingjiang Hu, Taro Tobo, Masakazu Yashiro, Atsushi Fujii, Akihiro Kitagawa, Tadashi Abe, Hajime Otsu, Shuhei Ito, Eiji Oki, Masaki Mori, Koshi Mimori
Cancer Genomics Proteomics. Jul-Aug 2021;18(4):521-529. doi: 10.21873/cgp.20277.PMID: 34183385
- Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer.
Yuta Kobayashi, Takaaki Masuda, Atsushi Fujii, Dai Shimizu, Kuniaki Sato, Akihiro Kitagawa, Taro Tobo, Yuki Ozato, Hideyuki Saito, Shotaro Kuramitsu, Miwa Noda, Hajime Otsu, Tsunekazu Mizushima, Yuichiro Doki, Hidetoshi Eguchi, Masaki Mori, Koshi Mimori
Cancer Sci. 2021 May 18. doi: 10.1111/cas.14969. Online ahead of print.PMID: 34008277
- Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
Mitsuko Fukunaga, Koshi Mimori, Takaaki Masuda, Qingjiang Hu, Kazutaka Yamada, Masaki Mori
Surg Today. 2021 Apr 2. doi: 10.1007/s00595-021-02273-x. Online ahead of print.PMID: 33797637
- Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Qingjiang Hu, Kentaro Nonaka, Hiroaki Wakiyama, Yu Miyashita, Yoshiaki Fujimoto, Tomoko Jogo, Kentaro Hokonohara, Ryota Nakanishi, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Takaaki Masuda, Eiji Oki, Koshi Mimori, Yoshinao Oda, Masaki Mori
Cancer Med. 2021 Mar 26. doi: 10.1002/cam4.3828. Online ahead of print.PMID: 33769705
- The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K.
Cancer Sci. 2021 Feb 19. doi: 10.1111/cas.14858. Online ahead of print.PMID: 33605496
- Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases.
Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H, Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K
PLoS Genet. 2021 Jan 21;17(1):e1009113. doi: 10.1371/journal.pgen.1009113. eCollection 2021 Jan.
PMID: 33476333